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Selective Neuronal Targeting in Prion Disease
1996); furthermore, it was assumed that specific pat-Stephen J. DeArmond,1,2,7 Henry SaÂnchez,1
terns of neuropathology were encoded by the genomeFruma Yehiely,2,8 Yin Qiu,1 Anne Ninchak-Casey,1
of the prion (Fraser and Dickinson, 1973; Bruce et al.,Valerie Daggett,6 Almerian P. Camerino,1
1976).Juliana Cayetano,1 Mark Rogers,2 Darlene Groth,2
Extensive searches by multiple laboratories for threeMarilyn Torchia,2 Patrick Tremblay,2 Michael R. Scott,2
decades have failed to reveal either a scrapie prion-Fred E. Cohen,3,4,5 and Stanley B. Prusiner2,3
associated virus or nucleic acid (Prusiner, 1982; Kellings1 Department of Pathology
et al., 1994; Manuelidis et al., 1997). From studies of2 Department of Neurology
passaging both inherited and sporadic human prion dis-3 Department of Biochemistry and Biophysics
eases into Tg(MHu2M)Prnp0/0 mice, we concluded that4 Department of Molecular and Cellular Pharmacology
prion diversity is enciphered in the conformation of its5 Department of Medicine
scrapie prion protein (PrPSc) (Telling et al., 1996b). SimilarUniversity of California
results were obtained for two strains of prions isolatedSan Francisco, California 94143
from mink by passaging in Syrian hamsters: the PrPSc of6 Department of Medicinal Chemistry
one strain, designated DY, was less resistant to limitedUniversity of Washington
proteolysis (Bessen and Marsh, 1994). Moreover, radio-Seattle, Washington 98195
labeled cellular prion protein (PrPC) bound to PrPSc puri-
fied from hamsters infected with the DY strain exhibited
a pattern of proteaseresistance similar to the PrPSc alone
Summary from DY prion-infected brain (Bessen et al., 1995). As
prions multiply, existing PrPSc seems to function as a
The pattern of scrapie prion protein (PrPSc) accumula- template in determining the tertiary structure of nascent
tion in the brain is different for each prion strain. We PrPSc molecules as they are formed from PrPC (Prusiner,
tested whether the PrPSc deposition pattern is influ- 1991; Cohen et al., 1994).
enced by the Asn-linked oligosaccharides of PrPC in While the foregoing scenario seems to be unprece-
transgenic mice. Deletion of the first oligosaccharide dented, it is supported by considerable evidence indi-
altered PrPC trafficking and prevented infection with cating that (1) PrPC and PrPSc have different conforma-
two prion strains. Deletion of the second did not alter tions, (2) propagation of prions requires synthesis of
PrPC trafficking, permitted infection with one prion PrPC by a host, (3) an infecting PrPSc must bind to PrPC,
strain, and had a profound effect on the PrPSc deposi- and (4) propagation involves replicating the conforma-
tion pattern. Our data raise the possibility that glyco- tion of PrPSc in PrPC.Within the context of these findings,
sylation can modify the conformation of PrPC. Glyco- we propose that selective targeting of neuronal popula-
sylation could affect the affinity of PrPC for a particular tions in the CNS is determined by cell-specific affinity
conformer of PrPSc, thereby determining the rate of of PrPSc for PrPC, which in turn determines brain region
nascent PrPSc formation and the specific patterns of differences in the rate of nascent PrPSc formation. Since
PrPSc deposition. SHaPrP is glycosylated at Asn residues 181 and 197
(Endo et al., 1989; Haraguchi et al., 1989), and sugar
chains are known to modify the conformation and inter-Introduction
action of some glycoproteins (O'Connor and Imperiali,
1996), it is reasonable to postulate that variations inThe prion diseases include Creutzfeldt-Jakob disease
complex CHOs may alter the size of the energy barrier(CJD) of humans as well as scrapie of sheep and bovine
that must be traversed during formation of PrPSc. If thisspongiform encephalopathy (BSE) (Gajdusek, 1977; Wells
is the case, then regional variations in CHO structureet al., 1987; Prusiner, 1996). In all of the naturally oc-
in the CNS could account for selective targeting, i.e.,curring and experimentally induced prion diseases,
formation of PrPSc in particular areas of the brain. Whilespongiform degeneration is found as well as an intense
such a mechanism may account for specific patternsastrocytic gliosis (DeArmond and Prusiner, 1997). When
of PrPSc distribution, our data argue that variations inamyloid plaques containing prion protein (PrP) are
glycosylation do not alter the strain-specific propertiesfound, such plaques are diagnostic. In rodents with ex-
of nascent PrPSc molecules. In fact, structural studiesperimental prion disease, the neuroanatomic pattern of
may provide an explanation for such phenomena, sincepathology was thought to be governed largely by the
the Asn-linked CHOs appear to be somewhat distantstrain of prion. For many years, the existence of prion
from the interface where PrPC and PrPSc are thought tostrains was used as evidence for a viral-like genome
interact during the formation of nascent PrPSc (Huangthat directs the synthesis of progeny prions (Dickinson
et al., 1994; Huang et al., 1996; Riek et al., 1996; Jameset al., 1968; Bruce and Dickinson, 1987; Dickinson and
et al., 1997; Peretz et al., 1997).Outram, 1988; Kimberlin et al., 1989; Ridley and Baker,
We report the construction of Tg mice expressing
PrPs mutated at one or bothof theglycosylation consen-
sus sites. These mutations resulted in aberrant topolo-7 To whom correspondence should be addressed.
gies of PrPC within the CNS, but pathologic point muta-8 Present address: Department of Genetics, University of Illinois at
Chicago, Chicago, IL 60607. tions adjacent to the consensus sites did not alter the
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Figure 1. Different Strains of Mice Inoculated
with RML Prions Exhibit Different Patterns of
PrPSc Accumulation
Patterns of PrPSc accumulation in coronal
sections of the brain in three inbred mouse
strains in the hippocampus and thalamus (A,
C, and E) and at the level of the inferior collicu-
lus (B, D, and F) following intrathalamic inocu-
lation of RML prions previously passaged in
CD-1 swiss mice. (A and B) C57BL mouse
exhibiting signs of neurologic dysfunction
was sacrificed at 126 days after inoculation.
(C and D) CD-1 mouse, 147 days. (E and F)
FVB mouse, 117 days. Am, amygdala; GC,
granule cell layer of the cerebellar cortex; Hb,
habenula; Hp, hippocampus; IC, inferior colli-
culus; LC, locus ceruleus; NC, neocortex; R,
dorsal nucleus of the raphe; vpl, ventral pos-
terior lateral nucleus of the thalamus; Hy, hy-
pothalamus; Th, thalamus.
distribution of PrPC. Tg mice with mutations of the sec- the cerebrum and brainstem in FVB mice. Only the pyra-
midal and granule cell layers of the hippocampus andond PrP glycosylation site exhibited prion incubation
the cerebellar cortex showed little or no immunostain-times of .500 days and unusual patterns of PrPSc depo-
ing. The PrPSc immunostaining in CD-1 mice was inter-sition. Our data support the possibility that glycosylation
mediate; it was more widely distributed in the brain com-can modify the conformation of PrPC and affect its affin-
pared to C57BL but weak or absent in some regionsity to a particular conformer of PrPSc, which results in
such as the hippocampus, amygdala, and hypothala-specific patterns of PrPSc deposition. The regional varia-
mus. Common to all three mouse strains was the pres-tions in PrP glycoforms may provide an explanation for
ence of immunostaining in the brainstem tegmentumthe selective targeting of neuronal populations in prion
and the absence of immunostaining in the cerebellardiseases where the accumulation of PrPSc precedes
cortex. Three animals of each mouse strain were exam-spongiform degeneration and reactive astrocytic gliosis.
ined, and no differences were found among the mice
of a particular strain. Each of these mouse strains is
Results homozygous for the Prnpa gene and, therefore, each
expresses PrPC-A with the same amino acid sequence.
PrPSc Accumulation in Three Strains of Mice Because all themice were inoculated with the RMLprion
RML (Rocky Mountain Laboratory strain) prions were strain passaged through CD-1 mice, finding different
inoculated into C57BL, CD-1, and FVB mice, all of which patterns of PrPSc accumulation argues that non-Prnp
carry the Prnpa gene. Each of these different strains genes must influence thephenotype of PrPSc deposition.
of mice exhibited different patterns of PrPSc deposition Thatnon-Prnp genes modify thepattern of PrPSc accu-
(Figure 1). C57BL mice weredistinguished from theother mulation prompted a series of hypotheses that might
inbred strains by little or no immunostaining in the hippo- explain these findings. Some investigators have argued
campus and neocortex and relatively weak immuno- that such non-Prnp genes are carried within the prion
staining in other brain regions. The most intense signals particle, but there is an expanding body of evidence
were found in the thalamus and brainstem. In contrast, that militates against this view (S. B. P. and M. R. S.,
1997). A more reasoned hypothesis, which is consistentPrPSc was uniformly and widely distributed throughout
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Figure 2. Mutations in the Asn-Linked Glyco-
sylation Consensus Sites Alter the Distribu-
tion of PrP in the Brains of Tg Mice
Histoblots show the distribution of wild-type
andmutant PrPC proteins in the hippocampus
of Tg mice expressing (A) wild-type SHaPrPC,
(B) SHaPrPC(T183A), (C) SHaPrPC(T199A), and
(D) SHaPrP(T183A, T199A). As controls, cryo-
stat sections were prepared for histoblots from
Tg mice expressing (E) wild-type MHu2M
PrPC, (F) MHu2M PrPC(D178N), and (G) MHu2M
PrPC(E200K). The diagram illustrates main
neuroanatomical features of the hippocam-
pus and adjacent structures. Hippocampal
structures: stippling shows the location of the
pyramidal cellsof Ammon's horn and theden-
tate gyrus. CA1, CA2, CA3 indicate locations
of the dendritic trees of three regions of Am-
mon's horn. CA4 is in the hilum of the dentate
gyrus. DG indicates the location of the den-
dritic tree of the dentate gyrus. CC, corpus
callosum; Fx, fornix; Hb, habenula; NC, neo-
cortex; Th, thalamus.
with a wealth of data, is that a non-Prnp gene(s) of the the Thr residues to Ala within the NXT consensus sites
(Taraboulos et al., 1990). Single and double glycosyla-host modifies the pattern of PrPSc deposition. Such gene
products might alter the synthesis, degradation, or post- tion site mutations were expressed in Tg mice deficient
for MoPrP (Prnp0/0), and the brains were analyzed fortranslational processing of PrPC, which is the substrate
for PrPSc. Because the number of patterns of PrPSc depo- the distribution of mutant SHaPrPC. Analysis was con-
fined to the hippocampal region in each case.sition are considerable, we asked if the variations in
Asn-linked glycosylation might be responsible for this Wild-type SHaPrPC was distributed almost exclusively
to the dendritic trees of the CA1 to CA4 regions of Am-phenomenon. We had previously shown that over 400
different glycoforms of PrPSc were found in the brains mon's horn and the dentate gyrus and was absent from
the cell bodies of pyramidal and granule cell layers inof scrapie-infected Syrian hamsters (Endo et al., 1989).
Such diversity was hypothesized to be the basis of prion the respective regions; additionally, it was largely absent
from white matter tracts such as the corpus callosumstrains (Prusiner, 1989), but this is now known not to be
the case (Telling et al., 1996b); nevertheless, PrP Asn- (Figure 2A). In contrast, mutation of either one or both
glycosylation consensus sites had a profound effect onlinked sugar chains might underlie selective neuronal
targeting. the anatomical distribution of SHaPrPC. Mutation of the
first glycosylation site alone or in combination with mu-
tation of the second site resulted in low levels of mutatedExpression of Glycosylation Site Mutant
PrPs in Tg Mice SHaPrPC, accumulation of SHaPrPC in nerve cell bodies,
and little SHaPrPC in the dendritic trees (Figures 2B andSince SHaPrPC contains complex-type oligosaccha-
rides attached to Asn residues 181 and 197, we mutated 2D). When the second glycosylation site was mutated,
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Table 1. Wild-Type SHaPrPC and Mutant SHaPrPC(T199A) Expression Levels in Tg Mice and Scrapie Incubation Times Inoculated
with Sc237 and 139H Prions
Incubation Time, Days 6 SEM (n)
PrPC Expression
Animal Line Levela Sc237 139H
Syrian Hamster 13 77 6 1 (48)b 167 6 1 (94)b
Tg(SHaPrP)7/Prnp1/1 43±83 54 6 1 (6)b 59 6 2 (6)b
Tg(SHaPrP)7/Prnp0/0 43±83 44 6 1 (6)c 47 6 0 (8)
Tg(SHaPrP)81/Prnp0/0 23±43 55 6 1 (20) 64 6 1 (12)
Tg(SHaPrP-T199A)315/Prnp0/0 23±43 555 6 0 (2) KAT (2)
Tg(SHaPrP-T199A)317/Prnp0/0 23±43 548 6 20 (4) KAT (4)
a Concentration of wild-type SHaPrPC and SHaPrPC (T199A) in the respective Tg mouse brains relative to the expression of wild-type
SHaPrPC in Syrian hamster brain as estimated by serial dilutions of brain homogenates on a dot blot.
b Hecker et al., 1992.
c Prusiner et al., 1993.
KAT 5 killed with atypical signs after 500 days but no clinical signs of scrapie or SHaPrPSc(T199A) identified.
the levels of SHaPrPC(T199A) were about the same as 139H prions developed signs of CNS dysfunction typical
of scrapie. In contrast, Tg(SHaPrP)81/Prnp0/0 mice ex-wild-type SHaPrPC; however, SHaPrPC(T199A) appeared
to be distributed to all neuronal compartments including pressing levels of wild-type SHaPrPC comparable to
those in Tg(SHaPrP-T199A)Prnp0/0 mice exhibited incu-the cell body, dendritic tree, and axons in the white
matter (Figure 2C). bation times of z50 days. The apparent slow conversion
of mutant PrPC into PrPSc in Tg(SHaPrP-T199A)Prnp0/0
mice contrasts with the more rapid conversion of ungly-Prion Disease in Tg Mice Expressing
cosylated PrPC into PrPSc in scrapie-infected neuro-Mutant PrPs
blastoma cells (Taraboulos et al., 1990).To examine the effects of mutations at the consensus
The neuroanatomic distribution of mutant SHaPrPScsites for Asn-linked glycosylation, we inoculated Tg mice
(T199A) deposition in Tg(SHaPrP-T199A)315/Prnp0/0 andexpressing mutant SHaPrPC with two different prion
Tg(SHaPrP-T199A)317/Prnp0/0 mice and the distributionstrains. Of the three different mutant PrPs, only Tg
of wild-type SHaPrPSc deposition in the Tg(SHaPrP)7/(SHaPrP-T199A) mice were found to support PrPSc for-
Prnp0/0 and Tg(SHaPrP)81/Prnp0/0 mouse lines weremation. We found that Sc237 scrapie prions but not the
compared (Scott et al., 1989; Prusiner et al., 1990). The139H strain transmitted to two Tg mouse lines express-
distributions of wild-type SHaPrPSc in Tg(SHaPrP)7/ing mutant SHaPrPC(T199A) (Table 1) (F. Y. et al., unpub-
Prnp0/0 and in Tg(SHaPrP)81/Prnp0/0 mice were similar,lished data). Susceptibility to scrapie in these Tg lines
and the distributions of mutant SHaPrPSc in Tg(SHaPrP-was dependent on the expression of the mutant SHaPrPC
T199A)315/Prnp0/0 and in Tg(SHaPrP-T199A)317/Prnp0/0in the absence of wild-type MoPrPC (Prnp0/0). The level
mice were similar; however, the distributions of wild-of expression of wild-type SHaPrPC and SHaPrPC(T199A)
type SHaPrPSc and mutant SHaPrPSc were markedly dif-in the Tg mouse lines was estimated by comparing seri-
ferent (Figure 3). One of the main differences was in theally diluted dot blots of 10% brain homogenates from
thalamus: wild-type SHaPrPSc was deposited through-uninfected Tg mouse and Syrian hamster brains (Table
out the thalamus, whereas little or no mutant SHaPrPSc1). The dot blots were immunostained for PrPC using
was found in that structure. Virtually all of the habenulaPrP-specific antibodies, and their relative concentra-
immunostained for wild-type SHaPrPSc, whereas mutanttions in Tg mice were expressed as multiples of the
SHaPrPSc accumulated in only a portion of the habenula.concentration of wild-type SHaPrPC in Syrian hamsters.
The patterns of wild-type SHaPrPSc and mutant SHaPrPScThe concentrations of mutant SHaPrPC in Tg(SHaPrP-
deposition were also different in the hippocampus, andT199A)315/Prnp0/0 and Tg(SHaPrP-T199A)317/Prnp0/0
the intensity of PrP immunostaining in the hypothalamusmice were similar to the amount of wild-type SHaPrPC
was greater for wild-type SHaPrPSc than for mutantexpressed in the Tg(SHaPrP)81/Prnp0/0 mouse line. Ap-
SHaPrPSc. Finally, amyloid plaques composed of prote-proximately twice as much wild-type SHaPrPC was pres-
ase-resistant wild-type SHaPrPSc could be identified inent in the brains of Tg(SHaPrP)7/Prnp0/0 mice compared
bothTg(SHaPrP)7/Prnp0/0 and Tg(SHaPrP)81/ Prnp0/0 miceto the Tg(SHaPrP)81/Prnp0/0 mouse line, which accounts
by their characteristic location and size (Scott et al., 1989);for the shorter incubation time in Tg(SHaPrP)7/Prnp0/0
no amyloid-like deposits were identified in Tg(SHaPrP-mice (Prusiner et al., 1990). The sites of wild-type and
T199A)315/Prnp0/0 or Tg(SHaPrP-T199A)317/Prnp0/0 mice.mutant SHaPrPSc deposition at the time clinical signs of
Sc237 scrapie developed in the respective Tg mouse
lines were determined by histoblot analysis for protease- Charge Isomers in Mice Expressing
Glycosylation Site Mutant PrPresistant PrPSc using PrP-specific antibodies (Tara-
boulos et al., 1992). Earlier studies had shown that PrP charge isomers were
due to variable sialylation of Asn-linked CHOs (BoltonTwo lines of Tg(SHaPrP-T199A)Prnp0/0 mice were in-
oculated with Sc237 and 139H strains of prions. After et al., 1985; Endo et al., 1989; Haraguchi et al., 1989). We
used transgenetics to confirm these earlier observations.500 days, those mice inoculated with Sc237 but not
Selective Neuronal Targeting in Prion Disease
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Figure 3. Regional Deposition of Wild-Type SHaPrPSc and Mutant SHaPrPSc(T199A) in Tg Mice Inoculated with the Sc237 Scrapie Prions
Previously Passaged in Syrian Hamsters
Histoblots of coronal brain sections through the thalamus and hippocampus were immunostained for protease-resistant PrPSc. (A and B)
Deposition of wild-type SHaPrPSc in the brains of Tg(SHaPrP)7/Prnp0/0 and Tg(SHaPrP)81/Prnp0/0 mice and (C and D) mutant SHaPrPSc(T199A)
in Tg(SHaPrP-T199A)315/Prnp0/0 and Tg(SHaPrP-T199A)317/Prnp0/0 mice. (E) Tg(SHaPrP-T199A)317/Prnp0/0 mice inoculated with the 139H
prion strain did not develop signs of scrapie, and no protease-resistant PrP accumulated in their brains; only weak, nonspecific staining is
seen. Similarly, no immunostaining was found in Tg(SHaPrP-T199A)315/Prnp0/0 mice inoculated with 139H (not shown). Arrows in (A) and (B)
indicate sites of PrP amyloid plaque formation. (F) Neuroanatomical diagram: Hb, habenula; Hp, hippocampus; Hy, hypothalamus; NC,
neocortex; ZI, zona incerta.
by comparing extracts from the brains of Tg mice ex- isomers expressed in the the cerebellum compared to
those in the hippocampus (Figures 4B and 4F). Thesepressing wild-type and mutant SHaPrPC molecules. A
large number of charge isomers of wild-type SHaPrP results suggest that the first oligosaccharide linked to
N181 is more sialylated than the one covalently boundwas found, but mutation of both Asn-linked glycosyla-
tion consensus sites reduced the number of isomers to to N197; furthermore, the higher concentration of
PrPC(T199A) may reflect increased stability comparedone major and two minor spots (Figures 4A and 4D).
Relatively fewer charge isomers were seen when one of to PrPC(T183A).
the two consensus sites was mutated to produce either
SHaPrPC(T183A) or SHaPrPC(T199A) (Figures 4B, 4C, 4F, Mutations Adjacent to the Glycosylation
Consensus Sitesand 4G).
In both the hippocampus and cerebellum, more Although the foregoing findings argue that the Asn-
linked oligosaccharides of PrPC have a profound effectcharge isomers with a wider pH range were found with
mutation of the second Asn-linked glycosylation con- on thescrapie phenotype, this conclusion requires qual-
ification. Since alteration of the glycosylation consensussensus site (T199A) (Figures 4B and 4F) than with muta-
tion of the first site (T183A) (Figures 4C and 4G). In other sites requires substitution of an Ala for a Thr, it was
not possible to determine unequivocally whether thesewords, the complex-type oligosaccharides attached to
N181 were more abundant and variable in structure than phenotypic changes were due to the loss of the CHOs
or to amino acid substitutions. To address this issue,those linked to N197.
Mutation of the first consensus site (T183A) resulted we examined the effects of other mutations known to
modify the extent of glycosylation and to cause inheritedin five or six PrP charge isomers in the hippocampus
(Figure 4C) but only one in the cerebellum (Figure 4G), prion diseases (Monari et al., 1994; Parchi et al., 1995;
Gabizon et al., 1996). We compared the patterns of PrPCwhich raises the possibility that the oligosaccharides
attached to residue N197 in the cerebellum are not sialy- immunostaining in the brains of Tg mice expressing
wild-type chimeric PrP with mutant PrP carrying eitherlated. Mutation of the second consensus site (T199A)
resulted in a shift toward neutral pH for the PrP charge the D178N or E200K mutation: the distribution of mutant
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Figure 4. Charge Isomers of Wild-Type or Glycosylation Site Mutant
SHaPrPs in the Hippocampus and Cerebellum of Tg Mice
(A and E) Wild-type SHaPrPC in hippocampus and cerebellum. (B
and F) Mutant SHaPrPC(T199A) in hippocampus and cerebellum. (C
and G) Mutant SHaPrPC(T183A) in hippocampus and cerebellum
with the first oligosaccharide deleted in hippocampus. (D) Mutant
SHaPrPC(T183A, T199A) in hippocampus. Western transfers immu-
nostained with anti-PrP 13A5 MAbs. Hp, hippocampus; Cb, cere-
bellum.
PrPs was indistinguishable from that of wild-type PrPC
(Figures 2E±2G). While these findings argue that the
altered distribution of PrPC in Tg mice expressing any
of the three glycosylation site mutant PrPs (Figures 2B±
2D) is due to the altered glycosylation state and not the
Figure 5. Patterns of PrPSc Accumulation in CD-1 Swiss and
substitution of Ala for Thr at residue 183 or 199, amino Tg(MoPrP-P101L)196/FVB Mice Inoculated with RML Prions De-
acid substitutions in PrP can have a profound effect on rived from Multiple Passages through CD-1 Mice Are Indistinguish-
the neuronal targeting of PrPSc deposition as described able from the Phenotype Associated with Continuous, Sequential
Passage of RML Prions in CD-1 Micebelow.
Histoblots of coronal brain sections through the thalamus and hip-
pocampus were immunostained for protease-resistant PrPSc. (A) De-Amino Acid Substitution Modifies PrPSc Deposition
position of PrPSc in the brain of a CD-1 mouse inoculated with RMLIn the course of studies on the transmission of prions
prions previously passaged in CD-1 mice. (B) Deposition of PrPSc
generated de novo in Tg mice expressing high levels of in the brain of a Tg(MoPrP-P101L)196/FVB mouse inoculated with
mutant MoPrP-P101L (Telling et al., 1996a), we found RML prions previously passaged in CD-1 mice. Note the marked
that RML prions inoculated into Tg(MoPrP-P101L)196/ change in the phenotypic pattern of PrPSc accumulation. (C and D)
Deposition of PrPSc in the brains of two CD-1 mice that were inocu-FVB mice expressing both wild-type and mutant PrP
lated with RML prions passaged in a Tg(MoPrP-P101L)196/FVBgave an unusual pattern of PrPSc deposition. This pattern
mouse. Pattern of PrPSc accumulation in two half coronal sectionsof PrPSc deposition in Tg196 mice following RML prion
is indistinguishable from that in (A). Arrows indicate the junction
inoculation was different from that in CD-1 mice (Figures region between the cingulate cortex and the frontal-parietal cortex.
5A and 5B). There was intense PrPSc immunostaining
throughout the neocortex, thalamus, inferior colliculus,
and whitematter tracts in CD-1 mice. In striking contrast,
there was little or no staining in these regions in It is not possible to determine how much of the PrPSc
signal was due to PrPSc(P101L) or to wild-type MoPrPScTg(MoPrP-P101L)196/FVB mice. The medial hypothala-
mus showed little or no immunostaining in CD-1 mice because we have no antibodies that distinguish these
two proteins. The presence of small numbers of mature,but was strongly immunopositive in Tg(MoPrP-P101L)
196/FVB mice. The only regions of the brain that exhib- periodic acid±Schiff (PAS)-positive, spiked ball±type
amyloid plaques of the kuru type in the region of theited similar levels of immunostaining in the two mouse
lines were the tegmenta of the midbrain, pons, and corpus callosum similar to those found in Tg196 mice
inoculated with extracts from Tg(MoPrP-P101L)H micemedulla.
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(Dickinson et al., 1968; Fraser and Dickinson, 1973). ForTable 2. Passage of RML Prions in Tg Mice Expressing Mutant
MoPrPC(P101L) many years, it was thought that the length of the incuba-
tion and the distribution of neuropathology changesIncubation Time,
were controlled primarily by the strain of prion, and,Donor Mice Recipient Mice Days 6 SEM (n)
thus, these two parameters were intrinsically linked. The
CD-1 CD-1 147 6 1 (19)
introduction of Tg mice expressing foreign PrP genesCD-1 Tg196 266 6 8 (6)
permitted the dissection and study of the factors influ-Tg196 CD-1 149 6 2 (9)
encing the incubation time. Such factors include (1) theTg196 CD-1 148 6 2 (9)
Tg196 CD-1 152 6 1 (10) level of PrPC expression (Prusiner et al., 1990), (2) the
PrPC sequence relative to that of PrPSc in the inoculumTg196 mice express both wild-type MoPrPC and mutant
(species of prion), (3) the tertiary structure of PrPSc inMoPrPC(P101L).
the inoculum (strain of prion) (Telling et al., 1996b), and
(4) compatibility of PrPC with protein X (Telling et al.,
1995; Kaneko et al., 1997b). Equally complex are the
argues that PrPSc(P101L) was formed in the present factors that modify the neuropathology of prion disease;
study when Tg196 were inoculated with RML(CD-1) pri- the first three cited above clearly influence the patterns
ons (n 5 4 mice) (Figure 5B). RML prions did not produce
of spongiform degeneration and reactive astrocytic
primitive or mature amyloid plaques in CD-1 mice as
gliosis.
judged from examination of three mice (Figure 5A). In
spite of the neuropathologic findings that argue for the
possibility that PrPSc(P101L) was produced, serial pas- PrPSc Accumulation and Neuropathology
sage of the prions from Tg196 mice into CD-1 mice
Several studies have documented that the deposition
contends that wild-type MoPrPSc was also formed in the
of PrPSc in brain precedes bothspongiform degeneration
Tg196 mice.
and reactive astrocytic gliosis, but the mechanism
RML prions previously passaged in CD-1 mice were
through which these neuropathologic changes occur is
inoculated into Tg(MoPrP-P101L)196/FVB mice; the
unknown (Bruce et al., 1989; Jendroska et al., 1991;
mice developed signs of CNS dysfunction after 266 days
Hecker et al., 1992; DeArmond et al., 1993). In one sce-
(Table 2). Brain homogenates from three different clini-
nario, PrPSc is thought to accumulate in lysosomes and
cally ill Tg196 mice were passaged back into CD-1 mice
trigger dysfunction of the neuron as these aberrantly
that exhibited incubation times of z150 days. The incu-
folded molecules are released into the cytosol (McKinleybation times of these mice are similar to those of RML
et al., 1991). The lysosome hypothesis was promulgatedprions passaged in CD-1 mice prior to injection into
originally because PrPSc could only be localized withTg196 mice. This finding of similar incubation times in
certainty in lysosomes and the adjacent cytosol by im-CD-1 mice before and after passage in Tg196 mice ar-
munogold electron microscopy of a scrapie-infected cellgues that the strain of mouse prions was unchanged
line (McKinley et al., 1991). A more likely scenario isduring transmission through Tg196 mice. Furthermore,
emerging from recent biochemical measurements ofthese findings contend that much of the PrPSc found in
PrPSc in cell fractions from scrapie-infected cell lines.Tg196 mice was formed from wild-type MoPrPC.
These indicate that PrPSc is formed from PrPC in caveo-A brain homogenate from a Tg(MoPrP-P101L)196
lae-like domains (CLDs) of the plasma membrane andmouse with signs of scrapie was inoculated into CD-1
accumulates within them as well as in lysosomes (Goro-mice, and their brains were frozen when they developed
dinsky and Harris, 1995; Taraboulos et al., 1995; Vey etsigns of scrapie. The pattern of PrPSc accumulation at
al., 1996; Kaneko et al., 1997a). Accumulation of PrPScall levels of the neuraxis (Figures 5C and 5D) was indis-
in CLDs may generate aberrant responses to stimulitinguishable from that found in CD-1 mice (Figure 5A)
mediated through the signal transduction system (An-inoculated with RML prions previously passaged more
derson, 1993). Accumulation of PrPSc at or near the sur-than four times in CD-1 mice; note the weak focal immu-
face of the cell may also be responsible for plasmanostaining in the superficial cerebral cortex at the junc-
membrane abnormalities, which include decreasedtion between the cingulate gyrus and frontal cortex (see
membrane fluidity, decreased binding affinity of brady-arrows in Figures 5C and 5D). As described above, the
kinin (Bk) to Bk receptors, decreased Bk-stimulated IP3scrapie incubation time for the passage from Tg196 into
response, and decreased Bk-stimulated intracellularCD-1 mice was similar to that found with continuous
calcium response (Kristensson et al., 1993; Wong etpassage in CD-1 mice (Table 2).
al., 1996). In fact, vacuolar degeneration (spongiformThese results argue that the sites of conversion of
degeneration) of neurons in prion diseases might bebestPrPC to PrPSc do not influence the strain properties of
explained by focal plasma membrane abnormalities ofprions. They argue for a cellular mechanism by which
prion propagation faithfully reproduces prion strain electrolyte and water homeostasis. A third scenario that
properties regardless of the cell type. could result either from abnormal plasma membrane
signaling or from the fact that PrPSc accumulates in sev-
eral subcellular compartments is a crippled stress re-Discussion
sponse triggered by a foreign, undegradable protein
(Kenward et al., 1994; Tatzelt et al., 1995). In scrapie-The most frequently measured phenotypic parameters
infected neuroblastoma cells, prion infection modifiesfor experimental prion disease in rodents are the length
of the incubation time and the pattern of neuropathology both the inducible and constitutive stress responses.
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Patterns of PrPSc Accumulation and Prion Strains Glycosylation and PrP Trafficking
Mutation of the first glycosylation site produced aOn this background, an equally perplexing question is
what controls the neuroanatomic topology of PrPSc ac- PrPC(T183A) that was abnormally sorted by the pyrami-
dal neurons of the hippocampus. This aberrant traffick-cumulation. For many years, the pattern of spongiform
degeneration and reactive astrocytic gliosis was used ing of PrPC(T183A) resulted in its accumulation in the
cell body (Figure 2B) and a complete absence of trans-as phenotypic markers for prion strains (Fraser and Dick-
inson, 1973). Different strains or isolates of prions were port into the dendritic trees of these neurons. Presum-
ably, the retention of PrPC(T183A) in the cell body pre-first recognized in goats (Pattison and Millson, 1961)
and then studied intensively in mice (Dickinson et al., vented it from trafficking to CLDs on the cell surface,
where PrPSc formation is thought to occur (Gorodinsky1968). The substantial diversity of prions as manifest
through the existence of strains posed a conundrum as and Harris, 1995; Taraboulos et al., 1995; Vey et al.,
1996; Kaneko et al., 1997a; Naslavsky et al., 1997). Thisto how the information for strains is encoded (Bruce and
Dickinson, 1987; Dickinson and Outram, 1988; Prusiner, contention is supported by the finding that Tg(SHaPrP-
T183A)Prnp0/0 mice were resistant to prions, while1991). In fact, in recent years, the existence of prion
strains was used as the main argument for the existence Tg(SHaPrP-T199A)Prnp0/0 mice developed scrapie but
only after greatly prolonged incubation times (Table 1).of a scrapie-specific nucleic acid.
Since recent data have begun to mount a convincing Mutation of the second glycosylation site produced a
PrPC(T199A) of which only a portion was abnormallycase for the enciphering of prion strain-specific informa-
tion in the conformation of PrPSc (Bessen and Marsh, sorted by the pyramidal neurons of the hippocampus,
since both the cell bodies and the surrounding neuropil1994; Telling et al., 1996b), we examined the issue of
how prion strain±host infections specify which cells ac- contained PrPC(T199A) (Figure 2C). Whether the abnor-
mal trafficking of PrPC(T199A) or an aberrant conforma-cumulate PrPSc. Since many patterns of PrPSc deposition
have been seen in prion diseases of rodents, a mecha- tion is responsible for the slowed formation of PrPSc in
Tg(SHaPrP-T199A)Prnp0/0 mice requires further investi-nism involving considerable variability is required. Gen-
erally, such mechanisms in biology use nucleic acids as gation. It is notable that the pattern of PrPSc accumula-
tion in Tg(SHaPrP-T199A)Prnp0/0 mice was highly re-a basis for varying phenotypes, but a wealth of evidence
argues that prions are devoid of RNA and DNA. Consid- stricted compared to that in wild-type mice inspite of the
greatly prolonged incubation times (Table 1; Figure 3).erable variation in prions can be found in the Asn-linked
oligosaccharides and the GPI attached to PrPSc (Endo
et al., 1989; Stahl et al., 1992). These complex CHOs One Strain Producing Multiple Patterns
are added to PrPC cotranslationally in the ER and are of PrPSc Deposition
modified as PrPC transits the Golgi on its passage to We found that a single strain can produce different pat-
the cell surface (Caughey et al., 1989; Taraboulos et al., terns of PrPSc accumulation depending on the PrP se-
1990). Only after PrPC reaches the plasma membrane quence and the animal species in which it is expressed.
does it enter the CLDs, where a small fraction is con- Yet, under these circumstances, the prion strain did not
verted into PrPSc in infected cells (Gorodinsky and Harris, change in agreement with recent studies, showing that
1995; Taraboulos et al., 1995; Vey et al., 1996; Kaneko inocula derived from different regions of the brain as
et al., 1997a). Notably, the composition and sequence well as from spleen retain their strain-specific properties
of these CHOs are already fixed as PrPC reaches the with only an occasional exception (Carp et al., 1997). If
cell surface and is converted into PrPSc; furthermore, the distribution of PrPSc in the brain was intrinsic to the
the variability in these CHOs is a function of the cell, replication of a particular strain, then the strain ought to
since the primary structure of PrPC is constant. mutate when its sites of replication are altered. From the
studies reported here,we have noevidence to suggestthat
Sugar Chains and PrP Conformation passage of the RML strain through Tg(MoPrP-P101L)
How might the CHOs attachedto PrPC explain the variety 196 mice altered the strain-specific characteristics, yet
of patterns of PrPSc deposition that are known to be the pattern of PrPSc accumulation differed substantially
modulated by (1) the level of PrPC expression, (2) the from that found in CD-1 mice (Table 2; Figure 5).
trafficking of PrPC, (3) the PrPC sequence relative to that
of PrPSc in the inoculum (species of prion), and (4) the
Selective Neuronal Targetingtertiary structure of PrPSc in the inoculum (strain of
While the foregoing studies argue that the Asn-linkedprion)? We hypothesize that the CHOs attached to PrPC
oligosaccharides of PrPSc do not encipher the character-modify the conformation of and/or stabilize its PrPSc-
istics of prion strains, the data support the possibilitybinding domain that modulates the conversion into
that selective neuronal targeting is due to neuron-spe-PrPSc. This kinetic view of PrPSc accumulation is consis-
cific differences in the conformation of PrPC owing to thetent with the hypothesis that some PrPC molecules are
CHOs. There are multiple reports of oligosaccharidesmore readily converted into PrPSc than others (Eigen,
altering protein conformation through either steric per-1996). When we immunostained histoblots for PrPSc, par-
turbation or modulation of the aqueous environmentticular regions were positive and others negative. It is
surrounding a protein (O'Connor and Imperiali, 1996).possible that many unstained areas produce PrPSc but
Asn-linked glycosylation causes a hemagglutinin pep-at a lower rate. It is noteworthy that some PrPSc diffuses
tide to adopt a more compact, folded conformation (Im-from one region of the brain to another, which compli-
periali and Rickert, 1995). Glycosylation of epitopes fromcates such analyses (DeArmond et al., 1987; Taraboulos
et al., 1992; DeArmond and Prusiner, 1993). the rabies virus glycoprotein has been found to disrupt
Selective Neuronal Targeting in Prion Disease
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of the plasmids carrying the mutant SHaPrP gene was linearizeda-helical structure and to induce formation of a b turn;
with BvlII, treated with Klenow, and ligated to SalI linkers (Newmoreover, it was found that the most dramatic effects
England Biolabs). Each of the mutant SHaPrP open reading framesoccurred on addition of a single, simple carbohydrate
was excised by digestion with SalI and XhoI and ligated to the SalI-
(Otvos et al., 1991). Glycosylation appears to influence cut cos.SHa.Tet cosmid expression vector (Scott et al., 1992). Not
disulfide bridges between serum IgM peptides, possibly alI fragments recovered from large scale DNA cosmid preparations
were used for microinjection into the pronuclei of fertilized oocytesby reducing the mobility of the peptide tailpieces (Wor-
from FVB or B6SJL mice as previously described (Scott et al., 1989).mald et al., 1991). Glycosylation of a highly conserved
Genomic DNA isolated from tail tissue was screened for the pres-15 residue loop region in the nicotinic acetylcholine re-
ence of incorporated transgene using a probe that hybridizes toceptor facilitates disulfide bridge formation, apparently
the 39 untranslated region of the SHaPrP gene contained in the
by bringing the termini of the loop into closer proximity cos.SHa.Tet vector (Scott et al., 1992).
(Rickert and Imperiali, 1995). In some cases, such as in
the CD2 receptor on T cells, the oligosaccharide binds Regional Brain Dissection
Hamster brains were dissected into seven regions: hippocampusto a positively charged cluster of five solvent-exposed
(Hip), cerebellum (Cbl), neocortex (NC), hypothalamus (Hth), thala-lysine residues, which destabilize the functionally rele-
mus (Th), caudate nucleus (Cd), and septum (S); and Tg mice werevant conformation in the deglycosylated molecule (Jones
dissected into two regions, hippocampus and cerebellum, for mea-
et al., 1992; Davis et al., 1995). surement of PrPC (Jendroska et al., 1991).
Within the context of the foregoing discussion, it is
interesting to reconsider reports stating that PrP glyco- Sample Preparation
All samples were homogenized in nine volumes lysis buffer (v/w)forms are strain-specific. Some investigators have ar-
(9.5 M urea, 2% Triton, 2% ampholyte, 5% b-mercaptoethanol) atgued that the relative levels of di-, mono-, and unglyco-
2000 rpm with ten strokes of a teflon pestle (clearance 0.1±0.15 mm)sylated PrPSc are strain-specific (Collinge et al., 1996;
in a 10 ml capacity Potter-Elvehjem tissue grinder. The homogenates
Hill et al., 1997). Such an approach has been applied to were centrifuged at 3000 3 g for 30 min; the supernatants were
brain extracts from British patients who recently died recentrifuged at 100,000 3 g for 60 min at 108C. The supernatants
from what is thought to be a new variant of CJD (vCJD) were stored at 2708C.
(Will et al., 1996). Unlike most sporadic and iatrogenic
Two-Dimensional Gel ElectrophoresisCJD cases, Western blots showed a preponderance of
Two-dimensional gel electrophoresis was performed as previouslythe diglycosylated PrP 27±30 (Collinge et al., 1996).
described with minor modifications (O'Farrell, 1975; O'Farrell et al.,While there is considerable evidence contending that
1977). In the first dimension, isoelectric focusing (IEF) was accom-
Asn-linked glycosylation of PrPSc is not strain-specific plished in tube gels 125 3 2.4 mm in size. Samples from different
(Borchelt et al., 1990; Caughey and Raymond, 1991; Vey brain regions containing approximately equal amounts of PrPC
based on densitometric analysis of immunoblots probed with anti-et al., 1996; Somerville et al., 1997), the kinetic argu-
PrP antibody were placed into each tube gel and subjected to 400ments set forth here provide an explanation as to how,
V for 16 hr followed by 850 V for 1 hr. The extruded first-dimensionunder some circumstances, a particular prion strain
gels were incubated in 62.5 mM Tris-HCl, 2% SDS, and 5%might be monitored by the relative concentrations of
b-mercaptoethanol at room temperature for 30 min before storage
specific PrPSc glycoforms. at 2708C. The frozen first-dimension gels were thawed by brief
That each brain region synthesizes a different set of incubation at 378C and electrophoresed immediately in the second
dimension in 12% acrylamide slab gels 150 3 145 mm in size andPrPC glycoforms provides a possible mechanism to ex-
3 mm thick as described by Laemmli (Laemmli, 1970). The pH gradi-plain neuronal targeting in the prion diseases. Our find-
ent of IEF gels was determined by cutting duplicate gels into 5 mming supports the hypothesis that modification of PrPC
sections and incubation for 2 hr at room temperature in deionizedglycosylation by mutagenesis alters the neuroanatomic
water.
topology of PrPSc deposition. This unites the properties
of prion strains and the characteristics of the prion dis- Immunoblotting
ease phenotype without needing to invoke a nucleic Following electrophoresis, the proteins were transferred to nitrocel-
lulose paper in 25 mM Tris, 192 mM glycine, 20% v/v methanol,acid. Moreover, such a mechanism offers an entirely
0.1% SDS (200 mA, 108C, overnight). After transfer, the membranesnovel explanation for the topology of the neurodegener-
were blocked at room temperature for 30 min with 5% nonfat dryation that occurs in the prion diseases. Whether similar
milk in 150 mM NaCl, 10 mM Tris-HCl (pH 8.0), and 0.05% Tween
CHO-mediated conformational changes feature in the 20 (TBST). Subsequently, the membranes were incubated with the
pathogenesis of some of the more common neurode- anti-PrP 3F4 monoclonal antibody (MAb) (Kascsak et al., 1987) di-
generative diseases such as Alzheimer's disease, Par- luted 1:2500, the anti-PrP 13A5 MAb (Barry and Prusiner, 1986)
diluted 1:2500, or the anti-PrP RO73 rabbit polyclonal antiserumkinson's disease, or amyotrophic lateral sclerosis re-
(Serban et al., 1990) diluted 1:5000 in TBST for 4 hr at room tempera-mains to be established.
ture. Staining was developed with the Protoblot alkaline phosphates
system (Promega) or by the enhanced chemiluminescence system
(ECL, Amersham) as described by the manufacturer.Experimental Procedures
Quantification and Analysis of ImmunoblotsAnimals
The intensity of immunostaining bands on Western transfers wasSyrian golden hamsters were purchased from Charles River Labora-
measured using a video-assisted computer densitometer. The iso-tories (Lakeview, NJ). Tg mice were produced that express SHaPrP
electric points on the transfer membrane were measured manually.mutated at the first, second, or both N-linked glycosylation sites as
Immunoblots were normalized to two internal standards.previously described for cultured ScN2a cells (Rogers et al., 1990).
The two consensus sites for addition of Asn-linked oligosaccharides
lie at residues 181 and 197 and consist of amino acids NIT and NFT, Acknowledgments
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